UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported) November 19, 2015
 
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
Delaware
 
1-15525
 
36-4316614
(State or other jurisdiction
of incorporation)
 
(Commission
file number)
 
(IRS Employer
Identification No.)
 
 
 
 
 
One Edwards Way, Irvine, California
 
92614
(Address of principal executive offices)
 
(Zip Code)
 
 
(949) 250-2500
Registrant’s telephone number, including area code
 
 
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-Commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-Commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





 
 
Item 8.01
Other Events

On November 19, 2015, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), issued a press release announcing a two-for-one stock split of the outstanding shares of the Company's common stock. A copy of the press release is attached as Exhibit 99.1.
 

 


Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits
 
 
99.1

Press Release dated November 19, 2015







SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 19, 2015
 
 
 
 
 
 
 
 
 
EDWARDS LIFESCIENCES CORPORATION
 
 
 
 
 
 
 
By:
/s/ Denise E. Botticelli
 
 
 
 
 
Denise E. Botticelli
 
 
Vice President, Associate General Counsel, and Secretary






Exhibit Index
 
 
 
 
 
Exhibit
Number
 
Description
 
 
 
99.1
 
Press Release dated November 19, 2015






Edwards Lifesciences Corporation
One Edwards Way Irvine, CA USA 92614
Phone: 949.250.2500 Fax: 949.250.2525
www.edwards.com

FOR IMMEDIATE RELEASE

Media Contact: Sarah Huoh, 949-250-5070
Investor Contact: David K. Erickson, 949-250-6826




EDWARDS LIFESCIENCES ANNOUNCES TWO-FOR-ONE STOCK SPLIT

IRVINE, CA, November 19, 2015 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that its board of directors approved a two-for-one split of the company’s outstanding shares of common stock to be effected as a 100 percent stock dividend. The company’s last stock split occurred in May 2010; this will be the company’s second stock split since it went public in April 2000.
Stockholders of record at the close of business on November 30, 2015, will be issued one additional share of common stock for each share owned as of that date. The additional shares will be distributed on December 11, 2015. The stock split will increase the number of common shares outstanding from approximately 108 million shares as of the record date, to approximately 216 million shares.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring.  Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at www.edwards.com.


Edwards, Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
###


Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Edwards Lifesciences Charts.
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Edwards Lifesciences Charts.